THE TAKETrailAI · auto-generated
Representative Carter's fundraising is evenly split between PAC/committee sources (51%) and individual donors (49%), with $251K in separate party and single-issue political contributions. Industry-tied contributions show concentration in health-sector fields, with Health Services comprising 22% of industry money, Pharmaceuticals & Biotech at 17%, and Lawyers & Lobbyists at 10%, a pattern reflected in his individual donor base where employed contributors work predominantly in these same sectors. His voting record includes 338 recorded votes and one stock trade disclosure filed under the STOCK Act.
Raised · all cycles$6.8M▲ 13% in ’24 vs ’22#63 in party · by cycle ↴
Top sector share22%Health Services
Donor-sector votes17on bills touching top donor sectors
FOLLOW THE MONEY
Left: who funds Carter (ribbon width = dollars) · right: their votes on bills classified as favoring vs limiting those sectors
“Favors / limits” is an AI classification of each bill's likely effect on the sector — a factual reading of the bill, not a claim about motive. Correlation, not causation. The named bills are in DOES THE MONEY MATCH THE VOTES? below.
DOES THE MONEY MATCH THE VOTES?
How Carter voted on bills touching their biggest donor sectors · 6 of 17 shown, ranked by sector money
Each dollar figure is Carter's total from that donor sector — shown on each related vote, not a per-vote amount. Correlation between funding and votes, not causation; many factors shape any single vote.
TOP SOURCES
1$915K
TEAM BUDDY
PAC
2$118K
AMERIS BANK
corporation
3$64K
STIFEL
corporation
4$46K
AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE PAC
PAC
5$45K
AMERICAN OPTOMETRIC ASSOCIATION POLITICAL ACTION COMMITTEE
PAC
ALIGNMENT SIGNALS
Sector-Aligned Voting90%
Earl L. "Buddy" Carter (R) voted YEA on 8 of 8 bills classified as favoring their donor sectors — #24 rate in the House
Rep. Buddy Carter voted YES on 8 of 8 bills classified by an AI model as favoring his top donor sectors—Pharmaceuticals & Biotech and Retail & Consumer—placing him at #24 among House members for this voting pattern. He voted YES on HR3537-117, the "Accelerating Access to Critical Therapies for ALS Act," classified as favoring the pharmaceutical sector, and also voted YES on 4 of 5 bills classified as limiting those same sectors.
Committee–Donor Overlap73%
Earl L. "Buddy" Carter (R) sits on the Energy and Commerce committee overseeing Health Services — their largest tracked donor sector (21%)
Rep. Earl L. "Buddy" Carter (R-GA) serves on the House Committee on Energy and Commerce, which has jurisdiction over the Health Services sector. Health Services comprises 21.1% of his identifiable donor base ($1.44M), ranking 10th among Republican members of Congress.
LEGISLATION
2 sponsored
COMMITTEES
Energy and Commerce
Budget
SIMILAR DONOR NETWORKS
Members funded by the same industries — overlapping donor networks may reflect shared policy interests.
Diana Harshbarger
R-TN · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Gus M. Bilirakis
R-FL · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Gregory F. Murphy
R-NC · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Roger Marshall
R-KS · Senate
Health ServicesLawyers & LobbyistsRetail & Consumer
James Comer
R-KY · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Jim Costa
D-CA · House
Health ServicesLawyers & LobbyistsRetail & Consumer